Harish Rajak

16PUBLICATIONS
15CO-AUTHORS
Metabolic medicineCancer geneticsChemotherapyHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 08, 2026
Mitochondrial Dynamics and Bioenergetic Reprogramming: Drivers of Cancer Therapy Resistance.

|Jun 18, 2026
Epigenetic-Genetic Crosstalk at the Cancer-Diabetes Interface: Convergent Molecular Pathways, Multi-Omics Biomarkers, and Dual Therapeutic Targets.

|May 28, 2026
Vacuolization as a Novel Approach to Cancer Therapy.

|May 15, 2026
HDAC Inhibitors in Hematological and Solid Tumor Therapy: Current Success, Challenges, and Future Directions.

|Oct 30, 2025
Targeting Microbiome-Derived Exosomes to Overcome Cancer Therapy Resistance: Mechanisms, Implications, and Opportunities.

Vaibhav Singh, Ekta Shirbhate, Rakesh Kore

|Aug 28, 2025
Heteroaryl-Capped Hydroxamic Acid Derivatives with Varied Linkers: Synthesis and Anticancer Evaluation with Various Apoptosis Analyses in Breast Cancer Cells, Including Docking, Simulation, DFT, and ADMET Studies.

Ekta Shirbhate, Biplob Koch, Vaibhav Singh

Pageof 3

Frequent Collaborators

13 joint publications

Ravichandran Veerasamy

9 joint publications

Ekta Shirbhate

9 joint publications

Amit K Tiwari

4 joint publications

Vijay Kumar Patel